| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.52B | 16.95B | 15.07B | 15.16B | 19.55B | 17.53B |
| Gross Profit | 8.23B | 7.40B | 5.53B | 5.13B | 5.50B | 6.37B |
| EBITDA | 7.57B | 7.48B | 7.63B | 7.25B | 7.03B | 5.85B |
| Net Income | 3.31B | 3.06B | 2.61B | 2.39B | 2.55B | 1.78B |
Balance Sheet | ||||||
| Total Assets | 73.07B | 74.55B | 71.41B | 71.02B | 70.08B | 72.37B |
| Cash, Cash Equivalents and Short-Term Investments | 72.00M | 109.00M | 88.00M | 83.00M | 745.00M | 1.14B |
| Total Debt | 32.06B | 32.39B | 32.34B | 32.63B | 32.31B | 33.91B |
| Total Liabilities | 40.49B | 42.10B | 39.54B | 39.29B | 37.96B | 40.45B |
| Stockholders Equity | 31.32B | 31.16B | 30.53B | 30.31B | 30.74B | 30.82B |
Cash Flow | ||||||
| Free Cash Flow | 3.89B | 3.22B | 3.01B | 4.15B | 3.35B | 4.43B |
| Operating Cash Flow | 6.31B | 6.25B | 5.63B | 6.49B | 4.97B | 5.71B |
| Investing Cash Flow | -2.63B | -3.51B | -2.63B | -4.17B | -2.17B | -2.31B |
| Financing Cash Flow | -3.79B | -2.84B | -2.89B | -3.01B | -3.15B | -3.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $57.13B | 11.07 | 34.93% | 7.31% | 6.16% | 14.35% | |
74 Outperform | $83.66B | 13.95 | 19.84% | 6.72% | -9.57% | ― | |
72 Outperform | $73.13B | 19.11 | 10.69% | 4.27% | 12.38% | 28.17% | |
72 Outperform | $58.25B | 18.41 | 15.47% | 5.61% | 41.04% | 9.18% | |
67 Neutral | $69.46B | 12.28 | 14.09% | 8.04% | 3.47% | -6.10% | |
67 Neutral | $93.32B | 28.03 | 20.84% | 3.35% | 9.77% | 17.44% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |